Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ: PHATHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PHAT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $550.94M
- Forward P/E
- 6.33
- EPS (TTM)
- -$1.26
- Dividend yield
- None
- 52-week range
- 6.52 – 18.31
- Day range
- 6.64 – 7.03
- Volume / Avg
- 1.63M / 1.39M
- Beta
- —
- Shares outstanding
- 80.90M
- Next earnings
- Oct 29, 2026
52-week range
PHAT stock today
Phathom Pharmaceuticals (PHAT) closed at $6.81 on Oct 7, up 0.44% (+$0.03), versus the S&P 500's 0.22% decline. Shares are 62.8% below their 52-week high of $18.31, set on Dec 23, 2025 and 4.4% above the 52-week low of $6.52, near the bottom of the past year's range. PHAT is down 59.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 37.2%.
Phathom Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$1.26), so its P/E ratio is not meaningful. Phathom Pharmaceuticals's next earnings report is expected on Oct 29, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Phathom Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2019
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $-0.01
Phathom Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CTMXCytomX Therapeutics Inc. | 2.55 | -0.39% | $555.64M | vs PHAT |
| MNPRMonopar Therapeutics Inc. | 83.78 | +5.29% | $562.35M | vs PHAT |
| CRMDCorMedix Inc. | 7.28 | 0.00% | $567.43M | vs PHAT |
| STTKShattuck Labs Inc. | 5.66 | -3.50% | $567.55M | vs PHAT |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs PHAT |
| EVOEvotec SE ADR | 1.61 | -1.23% | $572.18M | vs PHAT |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs PHAT |
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs PHAT |
Indexes, lists and sector
Phathom Pharmaceuticals stock FAQ
What is Phathom Pharmaceuticals's stock price today?
PHAT last traded at $6.81 as of Oct 7, 4:00 PM EDT, up 0.44% on the day. Prices are delayed at least 15 minutes.
When is Phathom Pharmaceuticals's next earnings date?
Phathom Pharmaceuticals is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $-0.01.
What is the PHAT 52-week high?
The 52-week high for PHAT is $18.31 and the 52-week low is $6.52. The stock is currently 62.8% below its high.